The use of newer progestins for contraception

R Sitruk-Ware, A Nath - Contraception, 2010 - Elsevier
The synthetic progestins used for contraception so far are structurally related either to
testosterone (estranes and gonanes) or to progesterone (pregnanes and 19-norpregnanes) …

MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives

EH Seeley, RM Caprioli - Trends in biotechnology, 2011 - cell.com
The molecular complexity of biological tissue and the spatial and temporal variation in the
biological processes involved in human disease requires new technologies and new …

Oral contraceptive use and breast cancer: a prospective study of young women

DJ Hunter, GA Colditz, SE Hankinson, S Malspeis… - … , biomarkers & prevention, 2010 - AACR
Background: Previous studies convincingly showed an increase in risk of breast cancer
associated with current or recent use of oral contraceptives from the 1960s to 1980s. The …

Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age

EF Beaber, DSM Buist, WE Barlow, KE Malone… - Cancer research, 2014 - AACR
Previous studies of oral contraceptives and breast cancer indicate that recent use slightly
increases risk, but most studies relied on self-reported use and did not examine …

Estetrol: from preclinical to clinical pharmacology and advances in the understanding of the molecular mechanism of action

C Gérard, JM Foidart - Drugs in R&D, 2023 - Springer
Estetrol (E4) is the most recently described natural estrogen. It is produced by the human
fetal liver during pregnancy and its physiological function remains unclear. E4 is the …

Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study

NA Burchardt, AH Eliassen, AL Shafrir, B Rosner… - American journal of …, 2022 - Elsevier
Background Oral contraceptive use has been associated with a higher breast cancer risk;
however, evidence for the associations between different oral contraceptive formulations …

Oral contraceptives and breast cancer risk overall and by molecular subtype among young women

EF Beaber, KE Malone, MTC Tang, WE Barlow… - … , biomarkers & prevention, 2014 - AACR
Background: Evidence suggests that recent oral contraceptive (OC) use is associated with a
small increased breast cancer risk; yet risks associated with contemporary OC preparations …

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers

J Kotsopoulos, J Lubinski, P Moller, HT Lynch… - Breast cancer research …, 2014 - Springer
It is not clear if early oral contraceptive use increases the risk of breast cancer among young
women with a breast cancer susceptibility gene 1 (BRCA1) mutation. Given the benefit of …

Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies

H Zhu, X Lei, J Feng, Y Wang - The European Journal of …, 2012 - Taylor & Francis
Background and objectives It has been suggested that taking oral contraceptives (OCs) may
increase breast cancer incidence. However, data in this regard are inconsistent. We …

[HTML][HTML] Polycystic ovary syndrome in adolescents: challenges in diagnosis and treatment

FR Tehrani, M Amiri - International journal of endocrinology and …, 2019 - ncbi.nlm.nih.gov
Results Oligo-anovulation in adolescents, if persistent, is a matter for concern. Hirsutism and
moderate to severe acne in adolescent females should be considered as clinical …